NCM
CVS icon

Novare Capital Management’s CVS Health CVS Stock Holding History

Novare Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,643
Closed -$210K – 201
2025
Q4 		$210K Sell
2,643
-2,637
-50% -$208K 0.02% 188
2025
Q3 		$398K Sell
5,280
-43,889
-89% -$3.01M 0.03% 151
2025
Q2 		$3.39M Sell
49,169
-5,252
-10% -$344K 0.28% 75
2025
Q1 		$3.69M Sell
54,421
-3,498
-6% -$209K 0.32% 70
2024
Q4 		$2.6M Sell
57,919
-36,313
-39% -$2.04M 0.22% 83
2024
Q3 		$5.93M Sell
94,232
-2,151
-2% -$125K 0.5% 67
2024
Q2 		$5.69M Buy
96,383
+6,081
+7% +$380K 0.51% 66
2024
Q1 		$7.2M Buy
+90,302
New +$6.9M 0.65% 63
2018
Q1 		– Sell
-48,382
Closed -$3.51M – 154
2017
Q4 		$3.51M Sell
48,382
-19
-0% -$1.38K 0.6% 72
2017
Q3 		$3.94M Buy
+48,401
New +$3.83M 0.69% 67
2017
Q2 		– Sell
-91,868
Closed -$7.21M – 125
2017
Q1 		$7.21M Sell
91,868
-2,932
-3% -$234K 1.67% 13
2016
Q4 		$7.48M Sell
94,800
-3,379
-3% -$273K 1.84% 9
2016
Q3 		$8.74M Buy
98,179
+3,417
+4% +$323K 2.29% 5
2016
Q2 		$9.07M Buy
94,762
+2,647
+3% +$264K 2.45% 3
2016
Q1 		$9.55M Sell
92,115
-3,662
-4% -$356K 2.68% 4
2015
Q4 		$9.36M Buy
95,777
+990
+1% +$97K 2.56% 4
2015
Q3 		$9.14M Sell
94,787
-1,952
-2% -$205K 2.52% 3
2015
Q2 		$10.1M Sell
96,739
-1,750
-2% -$179K 2.5% 3
2015
Q1 		$10.2M Sell
98,489
-3,265
-3% -$330K 2.52% 4
2014
Q4 		$9.8M Sell
101,754
-4,331
-4% -$382K 2.44% 5
2014
Q3 		$8.44M Sell
106,085
-2,260
-2% -$178K 2.07% 7
2014
Q2 		$8.17M Sell
108,345
-515
-0.5% -$38.9K 1.99% 8
2014
Q1 		$8.15M Buy
108,860
+2,600
+2% +$184K 2.17% 6
2013
Q4 		$7.61M Buy
106,260
+2,200
+2% +$141K 2.1% 6
2013
Q3 		$5.91M Buy
104,060
+3,810
+4% +$227K 1.84% 10
2013
Q2 		$5.73M Buy
+100,250
New +$5.81M 1.93% 7

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Novare Capital Management's CVS Position: Q1 2026 in Review

Novare Capital Management sold out of CVS Health (CVS) in Q1 2026, closing a stake of 2,643 shares — an estimated $210K sold.

Novare Capital Management first reported a position in CVS in Q2 2013 and held it in 26 quarters. The position peaked at $10.2M in Q1 2015. 1,876 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Novare Capital Management reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Novare Capital Management sold 2,643 CVS Health shares in Q1 2026, an estimated $210K.
  • Novare Capital Management first reported a position in CVS Health in Q2 2013 and held it in 26 quarters.
  • Novare Capital Management's CVS Health position peaked at $10.2M in Q1 2015.
  • 1,876 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Novare Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.